Skip to content
HowShorted

SkinHealth Systems Inc. Class short interest in 2025

In 2025, SkinHealth Systems Inc. Class's disclosed short interest ran from 7.03% of shares outstanding on 15 Jan 2025 to 13.09% on 31 Dec 2025, a change of +6.06 percentage points. The year's high was 13.70% on 30 Sep 2025 and its low 6.22% on 15 Apr 2025, averaging 9.82% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 39.10 days on 31 Dec 2025. Full history: SkinHealth Systems Inc. Class.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for SkinHealth Systems Inc. Class in 2025

2025 in figures

Start of year
7.03% (15 Jan 2025)
End of year
13.09% (31 Dec 2025)
Change
+6.06 pp
High
13.70% (30 Sep 2025)
Low
6.22% (15 Apr 2025)
Average
9.82%
Highest days to cover
39.10 (31 Dec 2025)
SEC filings marked
8

Every report in 2025

SkinHealth Systems Inc. Class short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 20257.03%12.54
31 Jan 20257.13%23.59
14 Feb 20256.93%20.08
28 Feb 20257.13%18.31
14 Mar 20256.85%8.2210-K filed, results (8-K)
31 Mar 20256.67%17.20
15 Apr 20256.22%8.68
30 Apr 20256.27%19.95
15 May 20256.43%4.8410-Q filed, results (8-K)
30 May 20256.68%13.55
13 Jun 20257.45%16.37
30 Jun 20259.28%8.60
15 Jul 20259.87%13.95
31 Jul 202510.01%18.90
15 Aug 202512.20%7.3410-Q filed, results (8-K)
29 Aug 202512.29%27.34
15 Sep 202513.14%12.90
30 Sep 202513.70%20.09
15 Oct 202513.57%19.63
31 Oct 202513.49%14.49
14 Nov 202513.63%12.4910-Q filed, results (8-K)
28 Nov 202513.42%27.77
15 Dec 202513.18%18.55
31 Dec 202513.09%39.10

See also: SkinHealth Systems Inc. Class's full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.